Found: 24
Select item for more details and to access through your institution.
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 1870, doi. 10.3390/ijms24031870
- By:
- Publication type:
- Article
Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 3, p. 631, doi. 10.1007/s10549-021-06240-5
- By:
- Publication type:
- Article
Tumor alkalization therapy: misconception or good therapeutics perspective? - the case of malignant ascites.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1342802
- By:
- Publication type:
- Article
Clinical trials on adjuvant chemotherapy for breast cancer.
- Published in:
- 1986
- By:
- Publication type:
- journal article
A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 2, p. 324, doi. 10.1007/s10637-023-01340-z
- By:
- Publication type:
- Article
Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 894, doi. 10.1007/s10637-019-00842-z
- By:
- Publication type:
- Article
EGFR T790M Mutation in TKI-Naïve Clinical Samples: Frequency, Tissue Mosaicism, Predictive Value and Awareness on Artifacts.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 10, p. 634, doi. 10.1159/000491441
- By:
- Publication type:
- Article
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 10, p. 605, doi. 10.1159/000449024
- By:
- Publication type:
- Article
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1664, doi. 10.1007/s11864-022-01019-2
- By:
- Publication type:
- Article
Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 7, p. 1471, doi. 10.1007/s00520-011-1235-4
- By:
- Publication type:
- Article
First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 6, p. 553, doi. 10.1007/s40261-018-0629-1
- By:
- Publication type:
- Article
Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 867, doi. 10.1007/s00280-021-04326-x
- By:
- Publication type:
- Article
Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 2, p. 339, doi. 10.1159/000500481
- By:
- Publication type:
- Article
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
An Open‐Label Study of the Safety and Efficacy of Tag‐7 Gene‐Modified Tumor Cells‐Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. e1303, doi. 10.1634/theoncologist.2020-0160
- By:
- Publication type:
- Article
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 292, doi. 10.1634/theoncologist.2015-0279
- By:
- Publication type:
- Article
A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel.
- Published in:
- Oncologist, 2016, v. 21, n. 1, p. 7, doi. 10.1634/theoncologist.2015-0152
- By:
- Publication type:
- Article
Quality of Life in the Trastuzumab for Gastric Cancer Trial.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 712, doi. 10.1634/theoncologist.2014-0058
- By:
- Publication type:
- Article
Tumor acidity: From hallmark of cancer to target of treatment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.979154
- By:
- Publication type:
- Article
Phase II dose-finding study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy.
- Published in:
- Medical Oncology, 2015, v. 32, n. 6, p. 1, doi. 10.1007/s12032-015-0623-x
- By:
- Publication type:
- Article
High efficacy of cisplatin neoadjuvant therapy in a prospective series of patients carrying BRCA1 germ-line mutation.
- Published in:
- Medical Oncology, 2015, v. 32, n. 4, p. 1, doi. 10.1007/s12032-015-0514-1
- By:
- Publication type:
- Article
Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation.
- Published in:
- Medical Oncology, 2014, v. 31, n. 10, p. 1, doi. 10.1007/s12032-014-0199-x
- By:
- Publication type:
- Article
Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer.
- Published in:
- Medical Oncology, 2013, v. 30, n. 2, p. 1, doi. 10.1007/s12032-013-0545-4
- By:
- Publication type:
- Article
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial.
- Published in:
- BioDrugs, 2023, v. 37, n. 3, p. 433, doi. 10.1007/s40259-023-00582-w
- By:
- Publication type:
- Article